Revenue GrowthSustained top-line expansion indicates continued customer demand and successful commercial execution. Over a 2–6 month horizon this durable revenue trend supports predictable cash inflows, provides headroom for reinvestment in capacity or R&D, and reduces execution risk versus peers with stagnant sales.

Gross Margin StrengthPersistently strong gross margins point to product-level pricing power or efficient manufacturing. This structural profitability buffer helps absorb raw-material volatility typical in chemicals, supports stable operating margins over time, and underpins the company’s ability to maintain operating profitability even if sales mix shifts moderately.

Equity Strength / Balance SheetAn expanding equity base provides a durable financial cushion against cyclical shocks and funds organic growth without excessive leverage. Over months this strengthens credit standing, lowers bankruptcy risk, and gives management flexibility to finance capex or absorb temporary cash-flow swings without immediate external financing.

Bears Say

Weak Cash Flow GenerationPersistent negative operating and free cash flows signal structural cash-generation problems that limit internal funding for capex, working capital, dividends, or debt reduction. Unless operations convert revenue into cash, the company will remain dependent on external financing, raising long-term financing and execution risk.

Rising Debt LevelsAn upward trend in total debt increases leverage and interest burden, reducing financial flexibility. If cash-flow issues persist, higher debt amplifies refinancing and solvency risk, constrains the ability to pursue growth projects, and can pressure margins as interest costs rise relative to operating earnings over months.

Profitability Volatility / EPS DeclineA marked EPS decline and reported net margin deterioration indicate recurring pressure on bottom-line profitability. This reduces retained earnings and internal capital for investment, and suggests either rising operating costs or pricing pressure—structural issues that could persist absent material operational or commercial fixes.

Shivalik Rasayan Ltd News

Shivalik Rasayan Limited Publishes Regulatory Advertisements

The latest update is out from Shivalik Rasayan Ltd ( ($IN:SHIVALIK) ). Shivalik Rasayan Limited announced the publication...

6M ago

Shivalik Rasayan Announces 47th AGM Details

Shivalik Rasayan Ltd ( ($IN:SHIVALIK) ) has issued an update. Shivalik Rasayan Limited announced the publication of a...

7M ago

SHIVALIK FAQ

What was Shivalik Rasayan Ltd’s price range in the past 12 months?

Shivalik Rasayan Ltd lowest stock price was ₹207.70 and its highest was ₹697.50 in the past 12 months.

What is Shivalik Rasayan Ltd’s market cap?

Shivalik Rasayan Ltd’s market cap is ₹3.30B.

When is Shivalik Rasayan Ltd’s upcoming earnings report date?

Shivalik Rasayan Ltd’s upcoming earnings report date is Jun 03, 2026 which is in 71 days.

How were Shivalik Rasayan Ltd’s earnings last quarter?

Shivalik Rasayan Ltd released its earnings results on Feb 13, 2026. The company reported ₹1.733 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.733.

Is Shivalik Rasayan Ltd overvalued?

According to Wall Street analysts Shivalik Rasayan Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Shivalik Rasayan Ltd pay dividends?

Shivalik Rasayan Ltd pays a Annually dividend of ₹0.5 which represents an annual dividend yield of 0.13%. See more information on Shivalik Rasayan Ltd dividends here

What is Shivalik Rasayan Ltd’s EPS estimate?

Shivalik Rasayan Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Shivalik Rasayan Ltd have?

Shivalik Rasayan Ltd has 15,750,365 shares outstanding.

What happened to Shivalik Rasayan Ltd’s price movement after its last earnings report?

Shivalik Rasayan Ltd reported an EPS of ₹1.733 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.843%.

Which hedge fund is a major shareholder of Shivalik Rasayan Ltd?

Currently, no hedge funds are holding shares in IN:SHIVALIK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Shivalik Rasayan Ltd

Shivalik Rasayan Ltd. engages in the manufacture of pharmaceutical and agrochemical products. Its products include organophosphorous based insecticides and chemicals. The company was founded by Rahul Bishnoi on March 16, 1979 and is headquartered in New Delhi, India.